5 completed, 1 terminated, 1 unknown, 1 withdrawn. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 5, Terminated 1, Unknown 1, Withdrawn 1 |
Follow Opportunistic Infections: new trials by email Literature Review of Opportunistic Infections trials Research Report on Opportunistic Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inflammation and Co-Infections in D²EFT NRTIs, Darunavir, Ritonavir - HIV-infection/Aids, Human Herpesvirus 4 Infections | Phase 4 | Withdrawn | Kirby Institute | 2021-02-01 | 2020-11-10 | |
| Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria Cotrimoxazole, Placebo - HIV-1-infection, Pneumocystis Pneumonia | Phase 4 | Completed | University of Bergen | 537 | 2017-03-30 | 2019-10-02 |
| Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda cotrimoxazole, Placebo - HIV Infections | Phase 4 | Unknown | MRC/UVRI and LSHTM Uganda Research Unit | 1650 | 2008-06-01 | 2008-06-05 |
| ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients MCT/LCT (1:1), MCT/LCT/omega-3 (5:4:1) - Critical Illness | Phase 4 | Terminated | B. Braun Medical SA | 212 | 2006-11-01 | 2013-07-19 |
| Antiretroviral Therapy for Advanced HIV Disease in South Africa Zidovudine, Stavudine, Didanosine - HIV | Phase 4 | Completed | National Institutes of Health Clinical Center (CC) | 1771 | 2004-01-01 | 2013-05-21 |
| When to Start Anti-HIV Drugs in Patients With Opportunistic Infections Emtricitabine/tenofovir disoproxil fumarate, Lopinavir/ritonavir, Stavudine - HIV Infections, AIDS-Related Opportunistic Infections | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 283 | 2003-03-01 | 2014-10-15 |
| Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance Cotrimoxazole (trimethoprim sulfamethoxazole) - HIV, Malaria | Phase 4 | Completed | Centers for Disease Control and Prevention | 1478 | 2002-02-01 | 2005-12-13 |
| A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush Fluconazole - Candidiasis, Oral, HIV Infections | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 948 | 2021-10-29 |
Acquired Immunodeficiency Syndrome (3) · HIV Infections (3) · AIDS-Related Opportunistic Infections (2) · Candidiasis, Oral (1) · Coinfection (1) · Critical Illness (1) · Cytomegalovirus Infections (1) · Diarrhea (1) · Disease Progression (1) · Epstein-Barr Virus Infections (1) · Escherichia coli Infections (1) · Hyperphagia (1) · Inflammation (1) · Malaria (1)
Infections (8) · Blood-Borne Infections (5) · Communicable Diseases (5) · Genital Diseases (5) · Immune System Diseases (5) · Immunologic Deficiency Syndromes (5) · Lentivirus Infections (5) · RNA Virus Infections (5) · Retroviridae Infections (5) · Sexually Transmitted Diseases (5) · Sexually Transmitted Diseases, Viral (5) · Urogenital Diseases (5) · Virus Diseases (5) · Pathological Conditions, Signs and Symptoms (4) · Bacterial Infections and Mycoses (3)
Trimethoprim, Sulfamethoxazole Drug Combination (3) · Lopinavir (2) · Stavudine (2) · Darunavir (1) · Didanosine (1) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Fluconazole (1) · Lamivudine (1) · Nucleosides (1) · Ritonavir (1) · Zidovudine (1) · dolutegravir (1) · efavirenz (1) · lopinavir-ritonavir drug combination (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · B. Braun Medical SA (1) · Centers for Disease Control and Prevention (1) · Kirby Institute (1) · MRC/UVRI and LSHTM Uganda Research Unit (1) · National Institutes of Health Clinical Center (CC) (1) · University of Bergen (1)
Puerto Rico (2) · South Africa (2) · United States (2) · Kenya (1) · Spain (1) · Tanzania (1) · Uganda (1)
Alfonso Bonet Saris, MD_Study Coordinator (1) · Andrew R. Zolopa, MD (1) · Andrew Ratsela, MD (1) · George Miiro, MSc, MBChB (1) · Heiner Grosskurth, PhD, MD (1) · Joel Manyahi, MD (1) · Mark Polizzotto, MD, PhD (1) · Mary J Hamel, M.D. (1) · Michael Polis, MD (1) · Mitchell Goldman (1) · Paula Munderi, MRCP, MBChB (1) · Scott G. Filler (1) · Teodoro Grau Carmona, MD_Study Coordinator (1)
PMID 10218526, PMID 10219064, PMID 11172138, PMID 11188837, PMID 12594647, PMID 15577626, PMID 16371882, PMID 19440326, PMID 20617176, PMID 20942650, PMID 21126955, PMID 21716078, PMID 22448211, PMID 32653726, PMID 33586013, PMID 36803640
2005 (1)